Ependymoma is a central nervous system (CNS) tumour that develops from ependymal cells, which line the brain's ventricles and the central canal of the spinal cord. It can occur in both children and adults and may develop in different areas of the brain or spinal cord. Modern classification increasingly incorporates molecular characteristics and tumor location, in addition to microscopic features, to define different ependymoma types.
Timely diagnosis and treatment matter because an ependymoma can compress or infiltrate nearby brain or spinal cord structures and may obstruct normal cerebrospinal fluid (CSF) flow. Depending on its location and behaviour, the tumor can cause increased intracranial pressure, neurological impairment, hydrocephalus, or spinal cord dysfunction. Early specialist evaluation helps determine the appropriate treatment strategy.
Causes
Risk Factors
Brain cancer surgery (craniotomy) : It is the primary treatment to diagnose, reduce the size of, or completely remove a brain tumor. The main goal is to safely remove as much of the tumor as possible while preserving vital brain functions like speech, movement, and cognitive abilities.
Cost Start From 12000Explore Options
Radiation Therapy : Radiation may be recommended after surgery for selected tumors, particularly when residual disease remains or when tumor characteristics indicate a higher risk of recurrence.
Chemotherapy : It has a limited role in many newly diagnosed ependymomas but may be considered in selected situations, particularly in children or recurrent disease when other treatment options are limited.
Cost Start From 1000Explore Options
Treatment for Recurrent Disease: Recurrent ependymoma may require additional surgery, radiation, systemic therapy or a combination of approaches depending on the location and previous treatments.
Multidisciplinary and Supportive Care: Neurology, neurosurgery, radiation oncology, pediatric oncology, rehabilitation and supportive-care specialists may work together to address tumor control, neurological function and quality of life.
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive tele-rehabilitation services designed to support Ependymoma patients in Singapore. These services include:









Singapore, Singapore

Novena, Singapore
Mount Elizabeth Novena Hospital located in Novena, Singapore is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

Singapore, Singapore
Gleneagles Hospital, located on Napier Road in Singapore, is a leading private healthcare institution offering comprehensive medical services and advanced clinical care. With 221 beds and a strong team of medical specialists, the hospital holds the Singapore Quality Class certification for excellence in healthcare. Its state-of-the-art facilities include ICU, HDU, NICU, Urgent Care Centre, operating theatres, radiology, endoscopy, laboratories, and rehabilitation units. Gleneagles specializes in orthopaedics, oncology, women’s health, and gastroenterology, offering tailored programs for cancer, bone, and gut health. With modern maternity packages and patient-friendly rooms, the hospital ensures compassionate, high-quality care focused on safety, comfort, and recovery.
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome

Medical Oncologist
14 Years of Experience
One of the finest Oncologist in New Delhi, India, Dr. Mohit Agarwal has worked with several world class multidisciplinary hospitals over the years. Dr. Mohit Agarwal has over 14+ years of experience in his field. The doctor treats and manages a wide range of conditions such as Stomach Cancer, Rectal Cancer, Breast Cancer, Brain Cancer View More
Last Reviewed - January 2026